Comparison of Zotarolimus-Eluting Stent vs Sirolimus-Eluting Stent for Diabetic Patients
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 256 participants.
Also called NCT01186107
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 256 participants
- Registry
-
NCT01186107
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT01186107. Randomized; single masking; primary purpose treatment. Start 2010-08 (registry gives no type); primary completion 2012-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of Zotarolimus-Eluting Stent vs Sirolimus-Eluting Stent for Diabetic Patients
- Acronym
- ESSENCE-DM2
- Condition
- Coronary Artery Disease
- Condition
- Diabetes
- Intervention (Device)
- Endeavor Resolute stent
- Intervention (Device)
- Cypher stent
- Lead sponsor
- Seung-Jung Park
- Collaborator
- CardioVascular Research Foundation, Korea
Record details
- Record id
cardio:ct-nct01186107- Content hash
920cbb524e2e478b5d49c80bb299793ce29f77a483749fc2ca77df8843c23b7a